(+)-Ketanserin Tartrate 250 mg | ≥98% LKT Laboratories, Inc. 5-HT2A and TRPV1 antagonist, potential α1-adrenergic antagonist. More Information Supplier Page × (+)-Ketanserin Tartrate
(+)-Ketanserin Tartrate 50 mg | ≥98% LKT Laboratories, Inc. 5-HT2A and TRPV1 antagonist, potential α1-adrenergic antagonist. More Information Supplier Page × (+)-Ketanserin Tartrate
(+)-Ketanserin Tartrate 10 mg | ≥98% LKT Laboratories, Inc. 5-HT2A and TRPV1 antagonist, potential α1-adrenergic antagonist. More Information Supplier Page × (+)-Ketanserin Tartrate
IOX2 100 mg | ≥98% LKT Laboratories, Inc. Prolyl hydroxylase inhibitor. More Information Supplier Page × IOX2
IOX2 25 mg | ≥98% LKT Laboratories, Inc. Prolyl hydroxylase inhibitor. More Information Supplier Page × IOX2
IOX2 5 mg | ≥98% LKT Laboratories, Inc. Prolyl hydroxylase inhibitor. More Information Supplier Page × IOX2
CAL101 5 mg | ≥98% LKT Laboratories, Inc. p110δ PI3K inhibitor. More Information Supplier Page × CAL101
CAL101 1 mg | ≥98% LKT Laboratories, Inc. p110δ PI3K inhibitor. More Information Supplier Page × CAL101
GDC-0980 10 mg | ≥98% LKT Laboratories, Inc. PI3K and mTOR inhibitor. More Information Supplier Page × GDC-0980
GDC-0980 5 mg | ≥98% LKT Laboratories, Inc. PI3K and mTOR inhibitor. More Information Supplier Page × GDC-0980
